Citigroup Loans collectively evaluated for impairment - associated allowance increased by 1.6% to $19.17B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.6%, from $18.51B to $19.17B. Over 5 years (FY 2020 to FY 2025), Loans collectively evaluated for impairment - associated allowance shows a downward trend with a -4.0% CAGR.
other_financing_receivable_allowance_for_credit_losses_c_414c67| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.81B | $16.51B | $15.43B | $14.37B | $14.84B | $15.31B | $16.05B | $16.80B | $17.16B | $17.22B | $17.74B | $18.02B | $18.00B | $18.16B | $18.22B | $18.51B | $18.91B | $18.94B | $18.87B | $19.17B |
| QoQ Change | — | -7.3% | -6.5% | -6.9% | +3.3% | +3.1% | +4.9% | +4.7% | +2.1% | +0.3% | +3.0% | +1.6% | -0.1% | +0.8% | +0.4% | +1.6% | +2.2% | +0.1% | -0.3% | +1.6% |
| YoY Change | — | — | — | — | -16.7% | -7.3% | +4.0% | +16.9% | +15.6% | +12.5% | +10.5% | +7.3% | +4.9% | +5.4% | +2.7% | +2.7% | +5.0% | +4.3% | +3.6% | +3.6% |